Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,707,385
-
Share change
-
-762,500
-
Total reported value
-
$6,906,898
-
Price per share
-
$0.18
-
Number of holders
-
37
-
Value change
-
-$138,911
-
Number of buys
-
13
-
Number of sells
-
12
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q1 2024
As of 31 Mar 2024,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,707,385 shares.
The largest 10 holders included
BVF INC/IL, Lynx1 Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., CITADEL ADVISORS LLC, ACADIAN ASSET MANAGEMENT LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CM Management, LLC, and NORTHERN TRUST CORP.
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.